System and method for dialyzer evaluation
US11141515B2 · kind B2 · utility
0Cited by
7References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2020 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Jul 30, 2040 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01D2311/246
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
Embodiments of the disclosure provide a method for evaluating dialyzers used in different medical applications (e.g., hemodialysis). Red blood cell volume lost in a dialyzer is monitored by obtaining blood flowrate measurements and hematocrit measurements at input ports and output ports of the dialyzer. The flowrate and hematocrit measurements are used to determine an accumulation of red cell blood volume in the dialyzer. The measurements may be obtained in a lab environment with an in-vitro blood source or may be obtained in a clinical setting with an in-vivo blood source from a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.